Gharebaghi, N., Nejadrahim, R., Mousavi, S. J., Sadat-Ebrahimi, S., & Hajizadeh, R. (2020). The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: A randomized placebo-controlled double-blind clinical trial. BMC Infect Dis.
Chicago-стиль цитированияGharebaghi, Naser, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, and Reza Hajizadeh. "The Use of Intravenous Immunoglobulin Gamma for the Treatment of Severe Coronavirus Disease 2019: A Randomized Placebo-controlled Double-blind Clinical Trial." BMC Infect Dis 2020.
MLA-цитированиеGharebaghi, Naser, et al. "The Use of Intravenous Immunoglobulin Gamma for the Treatment of Severe Coronavirus Disease 2019: A Randomized Placebo-controlled Double-blind Clinical Trial." BMC Infect Dis 2020.